Humanity ¡¤ Life Change ¡¤ Balance

HAUUL BIO

Realizing corporate values for the balance between human health and happy life

Next-generation cell therapy products platform

Developing an innovative new drug platform with the technology for selecting and producing high-sensitivity and
high-efficiency antibodies and the recombinant fusion protein technology

CAR cell therapy products
& Development of new target antibody drugs

Improving human cancer treatment through extensive anticancer treatment research that can simplify the manufacturing processes and therapies

Innovative next-generation cell therapy products platform

HAUUL BIO is using the technology to select and produce high-sensitivity and high-efficiency antibodies and the recombinant fusion protein technology to research and develop 3 original technology platforms differentiated from existing immune cell therapy technology.

MORE

Our Service

-

  • ShotCAR

    non-viral cell therapy products
    using the recombinant fusion
    protein CAR system

    The recombinant CAR protein-based cell therapy product technology that independently expresses and purifies recombinant protein and introduces it into immune cells rather than transduction and expression of genes by viruses


  • ModCAR

    non-viral cell therapy products
    using the scFv antibody fusion protein

    A broad-spectrum cell therapy technology that can be used for quick and efficient patient treatment by manufacturing the scFv antibody that can track the target antigen in a modular format and freely binding it to the immune cell


  • Cell surface modification cell therapy

    Technology that applies antibody-drug conjugate (ADC) after introducing the functional (for cell surface modification) recombinant fusion protein to the immune cell

    A cell therapy product technology that can apply chemotherapy and immunotherapy to a patient at the same time, and introduces customized ADC according to the patient's carcinoma

Balanced Health Recovery

HAUUL Bio produces various diagnostic and therapeutic antibodies based on the antibody production technology,
the antibody library production technology, and the high-quality antibody selection technology.
Our antibody technology will be innovative enough to change the world.